Golimumab

Results: 41



#Item
21Cysteamine / Thiols / Golimumab / Lenalidomide / Doxylamine / Ezetimibe / Chemistry / Organic chemistry / Amines

COMMONWEALTH of VIRGINIA Department of Medical Assistance Services DRUG UTILIZATION REVIEW PROGRAM Virginia Medicaid Drug Utilization Review (DUR) Board Quarterly Meeting

Add to Reading List

Source URL: www.dmas.virginia.gov

Language: English - Date: 2013-08-30 11:26:38
22Medical equipment / Medical ethics / Immunosuppressants / Monoclonal antibodies / Ustekinumab / Golimumab / Johnson & Johnson / Medical waste / Stericycle / Medicine / Centocor / Pharmacology

Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson & Johnson (J&J) company. J&J is committed to the health and wellbeing of families everywhere. Our commitment is evident in the v

Add to Reading List

Source URL: www.janssenbiotech.com

Language: English - Date: 2014-01-16 10:51:28
23Health / Monoclonal antibodies / Centocor / Medical equipment / Arthritis / Golimumab / Autoinjector / Infliximab / Rheumatoid arthritis / Medicine / Pharmacology / Immunosuppressants

SIMPONI® (golimumab) SIMPONI® (golimumab) MEDICATION GUIDE

Add to Reading List

Source URL: www.simponi.com

Language: English - Date: 2014-03-24 06:12:32
24Pharmaceuticals policy / Centocor / Drugs / Golimumab / Johnson & Johnson / Medicare / Health savings account / Prescription medication / Pharmacy / Medicine / Health / Pharmacology

Instant savings on your commercial or private health insurance out-of-pocket medication costs for SIMPONI® (golimumab)

Add to Reading List

Source URL: www.simponi.com

Language: English - Date: 2014-01-19 22:59:49
25Pharmacology / Adalimumab / Psoriasis / Leflunomide / Ustekinumab / Psoriatic arthritis / Etanercept / Golimumab / Infliximab / Immunosuppressants / Medicine / Immunology

PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-05-29 15:15:36
26Johnson & Johnson / Pharmacy / Health maintenance organization / Health / Medicine / Centocor / Healthcare in the United States / Golimumab

Payer Policy Summary Sheet for SIMPONITM (golimumab) Insurer_ ______________________________________ Plan Type (e.g., PPO, HMO)_______________________ Major Employers Utilizing Plan_ ____________________________________

Add to Reading List

Source URL: www.janssenaccessone.com

Language: English - Date: 2012-12-23 00:19:27
27Immunology / Rheumatoid arthritis / Tofacitinib / Disease-modifying antirheumatic drug / Adalimumab / Leflunomide / Etanercept / Infliximab / Golimumab / Immunosuppressants / Pharmacology / Medicine

Xeljanz® (tofacitinib tablets – Pfizer) To Initiate a Coverage Review, Call[removed]OVERVIEW Xeljanz is an inhibitor of the Janus kinases (JAK) pathways approved for the treatment of adults with moderately to s

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-08-12 13:02:45
28Immunology / Monoclonal antibodies / Arthritis / Autoimmune diseases / TNF inhibitor / Adalimumab / Etanercept / Golimumab / Infliximab / Medicine / Pharmacology / Immunosuppressants

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS August 2009 I.

Add to Reading List

Source URL: www.tricare.mil

Language: English - Date: 2009-10-21 16:35:34
29Immunology / Monoclonal antibodies / Centocor / Arthritis / Autoimmune diseases / Golimumab / Adalimumab / Rheumatoid arthritis / Infliximab / Medicine / Pharmacology / Immunosuppressants

PRIOR AUTHORIZATION POLICY Simponi™ (golimumab for subcutaneous [SC] injection – Janssen Biotech, Inc.) To Initiate a Coverage Review, Call[removed]OVERVIEW Simponi SC is a recombinant human monoclonal antibod

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-08-12 13:02:43
30Immunosuppressants / Monoclonal antibodies / Autoimmune diseases / Arthritis / Centocor / TNF inhibitor / Golimumab / Rheumatoid arthritis / Anakinra / Medicine / Pharmacology / Anatomy

Microsoft Word - uspi final track change for fda 21apr09.doc

Add to Reading List

Source URL: www.simponi.com

Language: English - Date: 2014-03-24 06:16:38
UPDATE